|
LSI Releases New Surgical Procedure Volumes Forecasts Factoring COVID-19 Impact on US, France, Germany, Italy, UK and Spain New reports and surveillance tools from LSI are forecasting the impact of the Coronavirus pandemic on surgical procedures across elective and non-elective categories. |
April 17, 2020 09:38 AM Pacific Daylight Time
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Leading medtech market research firm Life Science Intelligence (LSI) has been tracking surgical procedure volumes across 37 countries for the last decade. The firm is seeing massive shifts in volumes occurring as a result of the Coronavirus pandemic. As a result, the company has released new forecasts for the US and Big-5 Europe in its new COVID-19 Impact Tracker Platform. The company reports that data from China, Japan, South Korea and several other key countries will also be released in the forthcoming weeks.
From 2019 to 2020, surgical procedure volume in the US alone are projected to decline by 12%, followed by a substantial increase of almost 28% in 2021. This trend is seen around the world but varies by country and medical segment dramatically.
According to LSI CEO Scott Pantel, “This new tool was launched to support medical device & diagnostic executives as they navigate these challenging times. Our customers are trying to quantify the current impact to their markets so they can protect resources, and they are also preparing for the inevitable rebound so they can capitalize when the market turns. We’re here to give them independent, logical and thoroughly researched data so they can support their most critical decisions.”
According LSI’s most recent report for the US, “Surgical procedure volumes in the U.S. are experiencing a significant decline as a result of the COVID-19 pandemic, due to postponement or cancellation of elective procedures and, to a lesser degree, elimination of procedures that would have been performed on patients who die as a result of contracting COVID-19 disease. From 2019 to 2020, procedure volume is projected to decline substantially, followed by a major increase in 2021. The increase in 2021 is expected to result from the backlog of procedures postponed in 2020 which will add to the normal number of procedures estimated for 2021 in the absence of the COVID-19 pandemic. Not all of the procedures postponed in 2020 are expected to be recovered in 2021, since some patients who resort to alternative treatments (e.g., medical therapy, physical therapy) may decide to continue with those treatments and forgo surgery, although this trend will not occur for all types of procedures. In addition, it may be difficult for surgical services to accommodate such a large increase in volume, although the increase in comparison to 2021 procedure volume which is forecast to occur in absence of backlog procedures is only about 10%.”
These and other findings are detailed in the new reports from LSI. Procedures covered in the new series of reports include:
About Life Science Intelligence (LSI)
LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape
Contacts
Brad Shwam
Life Science Intelligence
714 847 3540 Tel
brad@lsintel.com
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2026 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy